MedPath

Discharge Time And Satisfaction Score Of Patients Undergoing Endoscopies Under Intravenous Remifentanil Sedatio

Phase 3
Conditions
Health Condition 1: 8- Other Procedures
Registration Number
CTRI/2024/06/069439
Lead Sponsor
Regional cancer centre,Trivandrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 18 to 75 years

Both males and females

ASA 1 and 2

Exclusion Criteria

Age less than 18 and more than 75 years

ASA 3 and above

Allergic to any opioids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To determine the time to discharge in patients undergoing endoscopies under remifentanil sedation. <br/ ><br>2. To assess the patient satisfaction to remifentanil sedation using Visual Analogue Scale (VAS) after the procedure.Timepoint: 1.Immediately after endoscopy <br/ ><br>2.10 minutes after procedure
Secondary Outcome Measures
NameTimeMethod
1.To evaluate sedation during endoscopies using Ramsay sedation score. <br/ ><br>2. To determine the total and supplemental dose of Remifentanil, required for sedation. <br/ ><br>3. To assess the surgeon’s satisfaction using a four point scale. <br/ ><br>4. To assess the change in hemodynamic variables during and after the procedure from <br/ ><br>baseline. <br/ ><br>5. To compare the sedation score and time to recovery with the existing data of <br/ ><br>fentanyl.Timepoint: During and After the endoscopic procedure
© Copyright 2025. All Rights Reserved by MedPath